Stattin P - Search Results

1

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.

Lindmark F, Zheng SL, Wiklund F, Bensen J, Bälter KA, Chang B, Hedelin M, Clark J, Stattin P, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J. Lindmark F, et al. Among authors: stattin p. J Natl Cancer Inst. 2004 Aug 18;96(16):1248-54. doi: 10.1093/jnci/djh227. J Natl Cancer Inst. 2004. PMID: 15316060

2

Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.

Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Grönberg H. Jonsson BA, et al. Among authors: stattin p. Int J Cancer. 2002 Apr 20;98(6):838-43. doi: 10.1002/ijc.10258. Int J Cancer. 2002. PMID: 11948460

3

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Stattin P, et al. Int J Cancer. 2002 May 1;99(1):124-9. doi: 10.1002/ijc.10313. Int J Cancer. 2002. PMID: 11948503

4

Plasma leptin is not associated with prostate cancer risk.

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T. Stattin P, et al. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):474-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12750247 No abstract available.

5

Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.

Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R. Palmqvist R, et al. Among authors: stattin p. Int J Cancer. 2003 Oct 20;107(1):89-93. doi: 10.1002/ijc.11362. Int J Cancer. 2003. PMID: 12925961

6

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. Stattin P, et al. Int J Cancer. 2004 Jan 20;108(3):418-24. doi: 10.1002/ijc.11572. Int J Cancer. 2004. PMID: 14648709

7

Obesity and colon cancer: does leptin provide a link?

Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Stattin P, et al. Int J Cancer. 2004 Mar;109(1):149-52. doi: 10.1002/ijc.11668. Int J Cancer. 2004. PMID: 14735482

8

-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.

Jonsson BA, Adami HO, Hägglund M, Bergh A, Göransson I, Stattin P, Wiklund F, Grönberg H. Jonsson BA, et al. Among authors: stattin p. Int J Cancer. 2004 Apr 10;109(3):348-52. doi: 10.1002/ijc.11629. Int J Cancer. 2004. PMID: 14961571 Clinical Trial.

9

Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.

Lindmark F, Jonsson BA, Bergh A, Stattin P, Zheng SL, Meyers DA, Xu J, Grönberg H. Lindmark F, et al. Among authors: stattin p. Prostate. 2004 May 1;59(2):132-40. doi: 10.1002/pros.10367. Prostate. 2004. PMID: 15042613

10

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.

Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. Stattin P, et al. J Clin Oncol. 2004 Aug 1;22(15):3104-12. doi: 10.1200/JCO.2004.10.105. J Clin Oncol. 2004. PMID: 15284261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters